 Register |
|
|
| Profile for Pseudo Biologist |
| Add PeopleMark | Ignore Member | Send Private Message | Recent Posts |
| Posts by Pseudo Biologist |
| Message | Subject | Recs | Date/Time (ET) |
| Smart? At least it is "validated" cf Synagis et al. A school of thought pose | momo-T/FIF | 03/30/2010 08:26:34 PM | |
| Sure, thanks, now I am blushing. But, can my rambling help anyone make any mone | Biogen - transition to operating company | 03/11/2010 07:19:23 PM | |
| We can start with the <i>what</i> As you may recall Rituxan is chimeric 2B8 | Biogen - transition to operating company | 03/11/2010 01:48:28 PM | |
| Not sure if what you are saying would or would not be in conflict with Schreiber | MEDX ... anybody following? | 03/06/2010 06:11:59 PM | |
| OK, are you saying the next Bay Area biotech beer bash should be held at this "s | momo-T/FIF | 03/04/2010 10:05:58 PM | |
| <i>Opebacan III (Xoma)</i> Apparently this is the same as or closely related | Biotech Valuation | 02/27/2010 05:00:28 PM | |
| <i>sorry for getting back to you so late on this</i> There are both good and | momo-T/FIF | 02/20/2010 05:36:43 PM | |
| Apparently the antibody has been around for 1/4 of a century now: http://www. | Biotech Valuation | 1 | 12/30/2009 02:33:41 PM |
| It is Science of October 9 2009, volume 326, page 215, as indicated already at t | Biotech Valuation | 2 | 11/15/2009 03:53:50 PM |
| Sure thing. The SEC link has further on the Immunex connection re Vectibix or A | MEDX ... anybody following? | 07/09/2009 01:30:44 PM | |
| My recollection is that denosumab was an Amgen pro | MEDX ... anybody following? | 07/08/2009 07:35:53 PM | |
| I was wondering the same too, but then I opened today's paper and there it was ( | Biotech Valuation | 06/16/2009 11:26:48 AM | |
| Here are some thoughts I had written some time ago - apologies to those with goo | Biotech Valuation | 1 | 02/23/2009 07:29:06 PM |
| Well, maybe maybe not: http://www.webmd.com/cold-and-flu/news/20090222/univer | Biotech Valuation | 1 | 02/23/2009 12:20:42 AM |
| Try 1992 or even earlier - this one may be the earliest with the term as such in | Biotech News | 02/12/2009 12:07:53 PM | |
| GHMM, Take a look at this: http://www.ncbi.n | MorphoSys AG (MOR) | 11/25/2008 05:24:02 PM | |
| I would have guessed Abgenix, but you are most likely correct that this used Med | MEDX ... anybody following? | 08/03/2008 09:40:48 AM | |
| Here is a report on a competing PD-1 antibody I was not aware of: http://clin | MEDX ... anybody following? | 05/15/2008 06:10:49 PM | |
| Scara, I wish I could say I did this call (better still act on it). The trut | Biotech Valuation | 04/17/2008 11:35:39 AM | |
| idos and tuck have further color on this work in the RNAi board: http://silic | Biotech Valuation | 03/29/2008 05:12:22 PM | |
| And here is slightly older news on a competing program for the same (interleukin | HuMAB companies | 03/17/2008 04:55:43 PM | |
| This ought to be one of the lamest PRs ever. I wonder if the electric company t | DYAX: Dyax Corp. | 02/29/2008 12:41:23 PM | |
| It is at the journal site at least for now (lmk if you want the full pdf). I ha | momo-T/FIF | 02/04/2008 12:13:44 PM | |
| X-mine Ughh, the pain!! PB | Biotech Valuation | 10/16/2007 11:28:23 AM | |
| Hey, just in case you feel tempted to invest in Satoris - weird choice of name B | Biotech Valuation | 10/16/2007 11:03:25 AM | |
| And I trust to do recognize the name of the first author? Unless, that is, it | Biotech Valuation | 10/16/2007 10:32:37 AM | |
| But, please, don't hold back and do tell us how you <b>really</b> feel about th | Biotech for less than cash value | 08/20/2007 07:12:17 PM | |
| Hear, hear. These things always feel a lot shorter than they are. Something | momo-T/FIF | 08/14/2007 09:27:22 PM | |
| Yes, they have continued to issue the funky dividend, which explains the odd num | Munch-a-Biotech Today | 07/11/2007 01:49:41 PM | |
| Speaking of legumes, here is another data point on CD200: http://ajp.amjpatho | Alexion Pharmaceuticals, Inc. (ALXN) | 04/24/2007 05:19:21 PM | |
| I think this really has changed since at least the late 90s when I started payin | Biotech Valuation | 04/11/2007 01:00:19 PM | |
| Miljenko, Thanks for the note. After reviewing this and past information I t | Regeneron Pharmaceuticals | 01/08/2007 04:55:17 PM | |
| Peter, It appears that increases in VEGF levels had been observed in human tr | Regeneron Pharmaceuticals | 01/05/2007 01:49:17 PM | |
| Neither Avastin nor its mouse precursor, originally known as A4.6.1, appreciab | Regeneron Pharmaceuticals | 01/04/2007 05:16:35 PM | |
| <i>but I think they do have some patents they'll try to defend</i> Here is | Momenta Pharmaceuticals Inc. | 12/11/2006 02:23:58 PM | |
| CD37 SMIP abstracts from ASH. Point to at least two MOA for this agent. I gues | Trubion | 11/09/2006 03:18:44 PM | |
| http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2006/11/08/BUG | Exelixis, Inc. (EXEL) | 11/08/2006 11:49:52 AM | |
| Good, gutsy call: http://www.siliconinvestor.com/stocktalk/msg.gsp?msgid=1795 | Indications -- Cancer | 09/24/2002 06:47:28 PM | |
| Tuck, here is an interesting post on CALP's BioAnalyzer by a "cyber cousin" (nip | Trickle Portfolio | 03/29/2001 02:35:06 PM | |
| <So is Bexxar 'death' a certainty?> I would not go that far, but it is probab | Corixa [CRXA] - cancer vaccines | 03/26/2001 12:27:04 PM | |
| Depressing for sure; even though I had made (slightly) worse investments within | Corixa [CRXA] - cancer vaccines | 03/20/2001 12:52:15 AM | |
| Peter, regarding pseudogenes or other false cDNAs, I guess it is possible. Peop | Biotech Valuation | 02/26/2001 04:37:42 PM | |
| Thanks Jim for the insight. It seems to me your view, if I understand it, doe | Biotech Valuation | 02/26/2001 12:46:46 PM | |
| <i>I think you can probably replace NDA with IND in that post</i> For sure, a | Human Genome Sciences, Inc. (HGSI) | 02/22/2001 01:00:55 PM | |
| Not exactly a "company" but definitely "HuMAb" http://www.pnas.org/cgi/conten | HuMAB companies | 02/14/2001 01:39:01 PM | |
| Thanks Nigel, here are the links to the abstracts (in 6 months or so, the full a | Sangamo BioSciences, Inc. SGMO | 02/14/2001 01:26:10 PM | |
| Well, the Wall Street Journal seems to be under the impression that CRA's draft | Biotech Valuation | 02/12/2001 12:51:13 AM | |
| <i>you're frigging WIMPS</i> Yeah, but darned <b>RICH</b> ones -g- Laughin | LEXG-Lexicon Genetics | 01/17/2001 03:59:47 PM | |
| TD, regarding (a), and as Rick pointed out, they have issued patents protecting | TELK -- Telik, Inc. | 01/17/2001 12:12:17 PM | |
| Thanks Nigel, see post 74. I do think most chemists would feel worse about bein | TELK -- Telik, Inc. | 01/16/2001 01:30:39 PM |
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ |
